How Much Longer Will This Company Be Around?

Discussion in 'Idev Technologies' started by Anonymous, Nov 11, 2009 at 10:32 PM.

Tags: Add Tags
  1. How do you sell a product with 8 reps to cover NA? Oh that's right you don't
     

  2. Anonymous

    Anonymous Guest

    Ok
    Here's the scoop
    No BS here

    They are down to 2 suitors for IDEV
    BSX and ABT

    No clue why either one of these companies would waste their money on this POS
    It's one thing if they bought it fir super cheap but I'm hearing some big dollars

    Another colossal screw up is going to be made by one of these companies
     
  3. Anonymous

    Anonymous Guest

    BSX actually makes sense as a potential suitor. The have an excellent presence in the Biliary stenting market. The Wallstent is still used there and very similar, IDEV never made a push to get into this market space (interesting enough, considering it's indicated for Biliary). But it's a great chance to bolster that portion of their product pipeline, and if they happen to make 30-40 million/yr selling this stent in endovascular use, great for them. But what about Covidien, they do have a position in the company and it's a space they want to be in?
     
  4. Anonymous

    Anonymous Guest

    Abbott buy-out $310 million...
     
  5. Anonymous

    Anonymous Guest

    Anyone know the price per share?
     
  6. Anonymous

    Anonymous Guest

    Game over.
     
  7. Anonymous

    Anonymous Guest

    Ha ha you morons. Abbot did buy the company (although I will agree the stent is a pos). Hope all you anonymous posters work for Abbot. Not it's in your bag idiots!